FDA approves rituximab plus chemotherapy for pediatric cancer indications
Oncology / Hematology
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Hematology | Pediatrics | Rituxan